Globus Medical rises on FDA nod for spine correction device

Globus Medical

15/05/2023 23:24

** Shares of medical device maker Globus Medical Inc
 GMED.N  rise 1.5% to $57.50 after the bell    
    ** Co says the U.S. Food and Drug Administration approved
its device to correct a type of abnormal curving of the spine in
young patients 
    ** The device, branded as Reflect, corrects progressive
scoliosis, using a flexible, durable cord to control the curve
while allowing growth of the spine- GMED   
    ** Up to last close, stock was down ~24% YTD 

 (Reporting by Mariam Sunny in Bengaluru)
 ((Mariam.ESunny@thomsonreuters.com;))